Lanean...
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
The clinical outcome of patients with a diagnosis of hormone receptor (HR)+ breast cancer has improved remarkably since the arrival of endocrine therapy. Yet, resistance to standard treatments is a major clinical challenge for breast cancer specialists and a life-threatening condition for the patien...
Gorde:
| Argitaratua izan da: | Cancer Cell Int |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130151/ https://ncbi.nlm.nih.gov/pubmed/34001143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01976-y |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|